Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco Dorsey Wright Momentum ETF
PDP
|
+$591M |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$240M |
| 3 |
Boston Scientific
BSX
|
+$194M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$193M |
| 5 |
Clarivate
CLVT
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.25B |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$809M |
| 3 |
Willis Towers Watson
WTW
|
+$664M |
| 4 |
AstraZeneca
AZN
|
+$658M |
| 5 |
Microsoft
MSFT
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.19% |
| 2 | Financials | 6.48% |
| 3 | Consumer Discretionary | 5.4% |
| 4 | Healthcare | 5.05% |
| 5 | Communication Services | 4.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
CALL
Linde
LIN
$221B
| $2.05M | ﹤0.01% |
7,000
-10,000
| -59% | -$3.04M |
|
2502
Celsius Holdings
CELH
$7.47B
| $2.05M | ﹤0.01% |
68,280
+6,132
| +10% | +$158K |
|
2503
Community Bank
CBU
$3.41B
| $2.05M | ﹤0.01% |
29,946
-25,403
| -46% | -$1.82M |
|
2504
Interactive Brokers
IBKR
$39.2B
| $2.04M | ﹤0.01% |
131,224
-10,676
| -8% | -$168K |
|
2505
Shoals Technologies Group
SHLS
$1.47B
| $2.04M | ﹤0.01% |
73,305
+50,496
| +221% | +$1.57M |
|
|
ACRE
2506
Ares Commercial Real Estate
ACRE
$236M
| $2.04M | ﹤0.01% |
135,359
+74,770
| +123% | +$1.13M |
|
2507
American States Water
AWR
$3.36B
| $2.04M | ﹤0.01% |
23,819
-13,642
| -36% | -$1.2M |
|
2508
Kontoor Brands
KTB
$4.63B
| $2.04M | ﹤0.01% |
40,790
-5,881
| -13% | -$326K |
|
|
HYACU
2509
DELISTED
Haymaker Acquisition Corp. III Unit
HYACU
| $2.04M | ﹤0.01% |
205,125
| – | – |
|
2510
Pricesmart
PSMT
$5.98B
| $2.04M | ﹤0.01% |
26,233
-7,542
| -22% | -$640K |
|
2511
Federal Signal
FSS
$7.63B
| $2.03M | ﹤0.01% |
52,668
+8,363
| +19% | +$329K |
|
2512
Dave & Buster's
PLAY
$377M
| $2.03M | ﹤0.01% |
53,013
+24,195
| +84% | +$875K |
|
2513
Emergent Biosolutions
EBS
$373M
| $2.03M | ﹤0.01% |
40,557
-61,001
| -60% | -$3.69M |
|
|
ISEE
2514
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $2.03M | ﹤0.01% |
125,017
-28,831
| -19% | -$314K |
|
2515
Dana Inc
DAN
$2.9B
| $2.03M | ﹤0.01% |
91,197
+65,086
| +249% | +$1.5M |
|
2516
PUT
Illumina
ILMN
$31B
| $2.03M | ﹤0.01% |
5,140
| – | – |
|
2517
Qfin Holdings
QFIN
$1.69B
| $2.03M | ﹤0.01% |
99,817
+35,117
| +54% | +$828K |
|
2518
Sally Beauty Holdings
SBH
$1.43B
| $2.03M | ﹤0.01% |
120,339
-5,924
| -5% | -$113K |
|
|
DIDI
2519
DELISTED
DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share
DIDI
| $2.02M | ﹤0.01% |
259,684
+257,184
| +10,287% | +$2.43M |
|
2520
Invesco S&P 500 Pure Growth ETF
RPG
$2.01B
| $2.02M | ﹤0.01% |
52,495
-75,100
| -59% | -$2.94M |
|
2521
Protolabs
PRLB
$1.79B
| $2.02M | ﹤0.01% |
30,350
-14,695
| -33% | -$1.15M |
|
2522
Revolution Medicines
RVMD
$39.9B
| $2.02M | ﹤0.01% |
73,294
-49,023
| -40% | -$1.43M |
|
|
ODP
2523
DELISTED
ODP
ODP
| $2.01M | ﹤0.01% |
50,040
-11,258
| -18% | -$507K |
|
|
ZIXI
2524
DELISTED
Zix Corporation
ZIXI
| $2.01M | ﹤0.01% |
284,259
+3,083
| +1% | +$22.3K |
|
2525
iShares US Treasury Bond ETF
GOVT
$43.6B
| $2.01M | ﹤0.01% |
75,713
-56,799
| -43% | -$1.52M |
|
Similar funds
Citigroup's Q3 2021 Portfolio in Review
As of Q3 2021, Citigroup held 6,611 positions worth $169B, up 1.9% from $166B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Citigroup deployed $5.8B of net new capital in Q3 2021, opening 423 new positions and adding to 2,034 existing holdings. Its largest new stake was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.25B trimmed.
- Citigroup's largest Q3 2021 buy was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
- Citigroup added most to Invesco Dorsey Wright Momentum ETF in Q3 2021, an estimated $591M increase.
- Citigroup's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.25B.
- Citigroup fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $809M.
- Citigroup's ten largest holdings make up 25% of its $169B portfolio in Q3 2021.
- Citigroup opened 423 new positions and closed 793 in Q3 2021.
- Citigroup's portfolio value rose 1.9% quarter-over-quarter to $169B.
Based on Citigroup's 13F filing for Q3 2021, filed 10 Nov 2021.